CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study
Titel:
CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study
Auteur:
Bergmeijer, Thomas O. Janssen, Paul W.A. Schipper, Jurjan C. Qaderdan, Khalid Ishak, Maycel Ruitenbeek, Rianne S. Asselbergs, Folkert W. van ‘t Hof, Arnoud W.J. Dewilde, Willem J.M. Spanó, Fabrizio Herrman, Jean-Paul R. Kelder, Johannes C. Postma, Maarten J. de Boer, Anthonius Deneer, Vera H.M. ten Berg, Jurriën M.